Dr. Jonathan S. Cross, MD

Dr. Cross practices at Neuroscience Consultants in Miami, Florida.

Dr. Cross' NPI, 1336146927, was assigned on June 28, 2005. Dr. Cross graduated from University of Miami, Miller School of Medicine in 1995. Dr. Cross holds Florida license ME0072217.

Dr. Cross' primary practice is Neuroscience Consultants, at 21000 Ne 28th Ave, Miami, FL 33180 in Miami-Dade County. The practice phone is (786) 924-1311.

Dr. Cross' primary practice is Neuroscience Consultants in Miami, Florida. Dr. Cross is also affiliated with Memorial Regional Hospital. The medical group on file is Memorial Division of High Risk Obstetrics. Dmand AI also links Dr. Cross to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cross practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cross' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cross is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Cross is licensed in Florida.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Cross treats.

CMS data shows 10,713 Medicare services from Dr. Cross across 15 procedure codes in 2024, for 724 Medicare patients. Medicare paid $226,928 for them. Every service was in an office.

CMS counts 724 Medicare patients who saw Dr. Cross in 2024. The largest group is 75 to 84, with 327 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cross' median patient age at 74, with 60% women.

In 2024, Dr. Cross wrote 2,538 Medicare Part D claims for 448 patients. 77% of them were for generic drugs. CMS names the drug for 2,294 of them, across 63 drugs with 11 or more claims each, at $1,947,716 in total drug cost. In 2023, CMS named 1,564 claims across 56 drugs.

Dr. Cross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cross as offering telehealth. CMS counts 42 procedures of skin biopsy by Dr. Cross, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Cross in 2017. Dr. Cross' most frequent co-authors are Tina Ataian Binazir, MD and Khema R. Sharma.

Dmand AI links Dr. Cross to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Cognitive Dysfunction and Cognition Disorders.

CMS Open Payments shows 986 general payments to Dr. Cross from 73 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Abbvie Inc. paid the most, $10,280.

Dmand AI lists 1 award for Dr. Cross, most recently CMS Stage 1 2012 in 2012.

Dr. Cross graduated from University of Miami, Miller School of Medicine in 1995. Dr. Cross is a member of AAN.

Dr. Cross is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.